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Abstract
In addition to the effector T-cells subsets, T-cells can also differentiate into cells that play a
suppressive or regulatory role in adaptive immune responses. The cell types currently identified as
regulatory T-cells (Tregs) include natural or thymic-derived Tregs, T-cells which express
Foxp3+CD25+CD4+ and can suppress immune responses to autoreactive T-cells, as well as
inducible Tregs, that are generated from naïve T-cells in the periphery after interaction with
antigens presented by dendritic cells. Inducible Tregs include TH3 cells, Tr1 cells, and Foxp3+-
inducible Tregs. Tregs have been shown to be critical in the maintenance of immune responses and
T-cell homeostasis. These cells play an important role in suppressing responses to self-antigens
and in controlling inappropriate responses to non-self-antigens, such as commensal bacteria or
food in the gut. For example, depletion of CD4+CD25+ Tregs from mice resulted in the
development of multi-organ autoimmune diseases. CD4+CD25+ Tregs and/or IL-10-producing Tr1
cells are capable of suppressing or attenuating TH2 responses to allergens. Moreover, adoptive
transfer of CD4+CD25+ Tregs from healthy to diseased animals resulted in the prevention or cure
of certain autoimmune diseases, and was able to induce transplantation tolerance. Clinical
improvement seen after allergen immunotherapy for allergic diseases such as rhinitis and asthma
is associated with the induction of IL-10- and TGFβ-producing Tr1 cells as well as FoxP3-
expressing IL-10 T-cells, with resulting suppression of the TH2 cytokine milieu. Activation,
expansion, or suppression of CD4+CD25+ Tregs in vivo by xenobiotics, including drugs, may
therefore represent a relevant mechanism underlying immunotoxicity, including
immunosuppression, allergic asthma, and autoimmune diseases.
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Introduction
The existence of suppressor T-cells and their role in the maintenance of immune
homeostasis was first proposed in the early 1970s (Gershon and Kondo, 1971). The
rediscovery of suppressor T-cells as regulatory T-cells (Tregs) took place in the 1990s, and it
is now fully accepted that distinct CD4+ T-cell subtypes, discriminated on the basis of
phenotype or cytokine secretion, play a critical role in maintenance of self-tolerance (Bloom
et al., 1992; Sakaguchi and Powrie, 2007). Tregs are a specialized subpopulation of T-cells
critical in the modulation of immune responses and in the maintenance of T-cell homeostasis
and self-tolerance (Figure 1). There are several types of Tregs, including natural, T-helper
(TH)-3 and T-regulatory (Tr)-1 subsets (Bach, 2003) as well as CD8+ Tregs (Filaci, 2007;
Funatake et al., 2008; Dinesh, 2010).
Natural Tregs are generated in the thymus as a part of thymic selection as well as in the
periphery in response to antigen exposure. Natural Tregs account for ≈5–10% of the total
CD4+ T-cells in the periphery; they express CD4, high levels of CD25 and are also positive
for the transcriptional repression factor fork-head box P3 (FoxP3). They are essential for the
prevention of autoimmunity and keeping the immune response under control (Sakaguchi et
al., 2006) as their absence results in multi-organ autoimmune disease in both mice and
humans. Adaptive or induced Tregs are regulatory cells that develop in the periphery, and
include Tr1 and TH3 cells that are CD4+CD25−FoxP3−. These Tregs secrete interleukin
(IL)-10 and transforming growth factor (TGF)-β, and regulate immune responses. It has
been suggested that in contrast to naturally occurring CD4+CD25+ Tregs, these cells
represent altered states of differentiation rather than a unique cell lineage (Jonuleit and
Schmitt, 2003). Tr1 cells are defined by their ability to produce large amounts of IL-10 and
low to moderate levels of TGFβ, whereas TH3 cells produce preferentially TGFβ. In vitro
stimulation of CD4+CD25−FoxP3− cells with TGFβ induces them to express FoxP3 and
secrete TGFβ. They contribute to the development of antigen-specific immunosuppressive
responses (Roncarolo and Levings, 2000). Immunoregulatory CD8+CD28− Tregs are present
and functional in many human tumors, being able to inhibit both T-cell proliferation and
cytotoxicity (Filaci, 2007). Data are accumulating showing the potential role of CD8+ Tregs
in other diseases, including chronic infection and autoimmunity (Dinesh, 2010).
The constitutive expression of CD25 has been considered to be a characteristic feature in the
identification of Tregs; however, activated T-cells also up-regulate CD25. CD4+CD25− T-
cells that express FoxP3 have been demonstrated during immune responses associated with
bacterial infection (Fontenot et al., 2005). The expression of FoxP3 is therefore the most
definitive marker to identify Tregs. CD25 and FoxP3 are also expressed by CD8+ Tregs.
Down-regulation of CD127, a subunit of the IL7R, is another mechanism to identify Tregs as
it is generally accepted that the CD25high/CD127low/− phenotype is specific to these cells
(Liu et al., 2006).
The balance between activated effector cells and Tregs is important for efficient immune
responses. Just as important as mounting an immune response, organisms have to control the
magnitude and duration of the response. Suppression of Treg function and/or number may
lead to unchecked immune responses resulting in autoimmune diseases, allergies, transplant
rejection, maternal intolerance of fetal alloantigens, septic shock and chronic inflammation
(Kondelkova et al., 2010). Enhancement of regulatory T-cell functions is a therapeutic goal
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for the treatment of many autoimmune diseases, and therapeutics such as rapamycin and its
derivatives, and corticosteroids have been shown to expand Tregs (Smith and Kumar 2008;
Powell and Delgoffe, 2010; Stary et al., 2011). Murine Tregs are more resistant than effector
T-cells to the apoptotic effects of dexamethasone in vitro and treatment of mice with
dexamethasone results in an increased proportion of Tregs in immune tissues (Chen et al.,
2004). A Treg suppression of inflammatory responses can be both a desired and undesired
effect depending on the disease. There is growing evidence that the suppressive effects of
Tregs may contribute to tumor growth (Colombo and Piconese, 2007), and to poor responses
to infectious agents and vaccines (Rouse et al., 2006). Therefore, the ability of xenobiotics
to inhibit or activate/expand Tregs may represent a relevant mechanism underlying chemical-
induced immunotoxicity (Fort and Narayanan, 2010).
As part of the 49th Annual Meeting of the Society of Toxicology in 2010, a symposium
entitled ‘Alterations in Regulatory T-Cells: Novel Pathways to Immunotoxicology’ was
convened to explore the role that Tregs may play in chemical-induced immunotoxicity. The
Symposium started with an ‘Introduction to the role of Tregs in immunity’ by Mohamed
Oukka, and was followed by presentations on ‘Role of immunoregulatory cells in chemical
and protein allergy’ by Raymond Pieters, ‘Induction of AHR-dependent Tregs: A novel
pathway for TCDD immunotoxicity’ by Nancy Kerkvliet, and ‘Safety assessment of
immunomodulatory biologics post-TGN1412: The promise and challenges of regulatory T-
cell modulation’ by Rafael Ponce. The purpose of this review article is to highlight the role
of regulatory T-cells in allergy and in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced
immunosuppression; a separate paper will deal with the pharmacological modulation of
regulatory T-cells.
Role of immunoregulatory cells at sites of exposure
The identification of Tregs capable of suppressing responses mediated by TH1 and TH2 cells
has prompted a paradigm shift in our understanding of the regulation of immune responses.
Regulatory T-cells, including Tr1 and TH3, are crucial for the induction of tolerance to food
antigens, and in the maintenance of tolerance at mucosal surfaces (Battaglia et al., 2006; Lan
et al., 2007). The skin, the respiratory and the gastrointestinal tract are continuously exposed
to a large number of antigens, representing a relentless challenge to the immune system. An
appropriate immune response must be able to differentiate between harmful and innocuous
antigens. To protect the host, mechanisms must be in place to prevent deleterious reactions,
such as immune responses to self-antigens, immune response to food antigens in the
intestine, or exaggerated immune responses to benign environmental antigens. One key
adaptation to the mucosal microenvironment is the generation within, or recruitment to the
mucosal surface of Tregs (Allez and Mayer, 2004). Disturbance of normal immunoregulatory
processes at mucosal surfaces, i.e., the breaking of tolerance, may occur, resulting in
sensitization to chemicals, certain pharmaceuticals and food or airborne proteins.
Key components of the mucosal microenvironment include the luminal surface, epithelial
cells, the lamina propria, and mucosal-associated lymphoid tissues (MALT), which can be
found within the mucosal layers. The mucosal epithelium forms a tight protective barrier
facilitated by integral membrane proteins and adhesion molecules, while the thick mucous
secreted by specialized epithelial cells such as goblet cells provides another important
barrier. Beneath the epithelial barrier, the lamina propria plays a critical role in host defense
with its network of capillaries and lymphatics.
Communication is constantly established between the external environment and the host
immune system. Mucosal epithelial cells actively participate in mucosal immunity through
production of anti-microbial peptides, chemokines, and cytokines, and are equipped with
pattern recognition receptors (PRRs) including Toll-like receptors and nucleotide-binding
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oligomerization domain (NOD) receptors: such cells also have antigen-presenting capability
(Kunisawa et al., 2007).
Functional and customized Treg cells
Naïve CD4+ T-cells can differentiate into many different subsets of TH effector cells,
notably TH1, TH2, TH9, and TH17 cells. The functional specialization of these various CD4+
T-cell subsets is due to the differential expression of ‘master’ transcription factors, namely
retinoic acid receptor-related orphan receptor-γt (RORγt), T-bet, and GATA-binding
protein 3 (GATA3), which turn on distinct programs of gene expression that control T-cell
function and migration (Littman and Rudensky, 2010). However, each of these responses is
pro-inflammatory and, in some circumstances, can damage tissues and lead to
autoimmunity. Furthermore, TH1, TH2, and TH17 cells express various chemokine receptors
that help guide these cells into appropriate tissues in which these cells are needed to fight
various pathogens.
Recently, several groups demonstrated that Treg cells are not all created equal; various
natural-occurring Treg subsets exist and express transcriptional factors and chemokine
receptors commonly found in either TH1 or TH17 cells (Chaudhry et al., 2009; Koch et al.,
2009; Zheng et al., 2009). These Tregs are rather specialized in preferentially suppressing
TH1 or TH17 cells. T-bet is the master transcription factor controlling the differentiation,
migration, and function of interferon (IFN)-γ-producing TH1 cells (Szabo et al., 2000).
Interestingly, T-bet is also expressed by a subset of Treg cells, and is required for Treg cell
homeostasis and function during polarized TH1-type immune response (Koch et al., 2009).
Finally, deletion of signal transducer and activation of transcription-3 (STAT3) in Treg cells
results in the development of a spontaneous fatal intestinal inflammation that is
characterized by excessive IL-17 production, but normal levels of TH1-associated
inflammatory cytokines; this indicates that there is selective dysregulation of TH17-type
responses in the absence of STAT3-expressing Treg cells (Chaudhry et al., 2009). The
mechanisms by which T-bet and STAT3 control Treg cell activity during TH1, TH2, and
TH17 cell-mediated responses are still unclear, but are likely to involve a combination of
influences on Treg cell migration, function and homeostasis. Additionally, loss of these
transcription factors may affect the functional properties of Treg cells.
From these data, a model emerges in which selective expression or activation of
transcriptional regulators associated with TH1, TH2, and TH17 cells drives the phenotypical
and functional specialization of Treg cells, and the expression of subset of specific genes
needed to restrain these different types of CD4+ T-cell responses.
Role of immunoregulatory cells in chemical and protein allergy
As early as 1970, studies in guinea pigs demonstrated that dermal sensitization to 2,4-
dintrochlorobenzene (DNCB) is subject to tolerance induction by oral pre-exposure to
DNCB (Lowney, 1971). In rodents, tolerance induction could be prevented by
cyclophosphamide, which has been shown to inhibit Tregs (Ikezawa et al., 2005).
Subsequently, in the 1980s and 1990s, the mechanisms regulating sensitization became
clearer through studies using multiple rat strains to examine autoimmune phenomena,
particularly following exposure to mercuric chloride (Pelletier et al., 1988, 1990; Mathieson
et al., 1991; Kosuda et al., 1994). Brown Norway rats recovering from mercury induced
autoimmunity became resistant to disease induction upon re-exposure to the same
compound. A similar phenomenon was observed in rats treated with and then re-exposed to
D-penicillamine (Masson et al., 2004; Seguin et al., 2004) and nevirapine (Shenton et al.,
2003). In mice, similar immunoregulatory processes were found to occur in response to
procainamide (Layland et al., 2004), nickel (Roelofs-Haarhuis et al., 2004), and contact
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sensitizers such as DNCB (Ju et al., 2003). Adoptive transfer and/or depletion of specific T-
cell populations in these rodent models of allergy and autoimmunity reinforced the concept
that active regulation by CD4+ and CD8+ T-cells is one of the key mechanisms for the
maintenance of self-tolerance and protection from sensitization and self-reactivity (Field et
al., 2003; Roelofs-Haarhuis et al., 2004; Seguin et al., 2004; Shenton et al., 2005).
Additional regulatory mechanisms for compounds that induce hypersensitivity include NK-
T cells, dendritic cells (DC), and Kupffer cells. When activated, these cells have been shown
to induce and/or expand Treg (Ju et al., 2003; Roelofs-Haarhuis et al., 2004). Tolerance, and
induction of regulatory mechanisms to protein allergens, is dependent on route of exposure,
dose, genotype, gender, and age (neonatal tolerance; Field et al., 2000, 2003). Oral exposure
can induce anergic T-cells with regulatory activity (Artik et al., 2001) and the presence of
commensal organisms, CD8+ intraepithelial lymphocytes, and DC in the gut foster a
tolerogenic environment (Weiner et al., 2011). It has been suggested that low dose oral
exposure to protein allergens favors the induction of Tregs, whereas higher doses favor the
induction of anergy or deletion of reactive T-cells (Weiner et al., 2011). Low dose oral
tolerance has been shown to prevent mercury induced autoimmune disease (Szeto et al.,
1999; Pelletier et al., 1990; Mathieson et al., 1991) with both compound-specific and non-
specific T-cell regulation described (Layland et al., 2004). For example, CD8+ suppressor
cells from mercuric chloride-exposed rats appear to act through similar regulatory cytokines
as has been described for CD4+ Tregs, i.e., TGFβ and IL-10, as well as via IFNγ- and
receptormediated regulation (e.g., CTLA-4).
Orally-induced tolerance is of particular relevance in case of food allergy, where there is a
lack of tolerance and proper immunoregulation to specific proteins (Mowat et al., 2003).
Several mouse studies with food allergens indicate that CD25+ Tregs are at least of some
importance in preventing responses to peanut (van Wijk et al., 2007) and milk proteins
(Schouten et al., 2010). However, other regulatory processes may also be involved,
including IFNγ-producing cells, other regulatory T-cells (Rezende, 2011), gδ T-cells (Bol-
Schoenmakers et al., 2011), and regulatory mucosal DC (Smit et al., 2011).
Induction of AhR-dependent Tregs: A novel pathway for TCDD immunotoxicity
TCDD is an aryl hydrocarbon receptor (AhR) ligand that induces immunosuppression in
experimental animals, including thymic involution, decreased antibody production and
cytotoxic T-lymphocyte development, and increased susceptibility to a variety of infectious
diseases (Kerkvliet et al., 2002). It has been shown that the immunosuppressive effect of
TCDD in mice correlated with CD25+CD4+ regulatory T-cell generation (Funatake et al.,
2005; Kerkvliet et al., 2009).
Like natural Tregs, TCDD-derived CD4+ T-cells did not produce IL-2 and their suppressive
function was contact dependent (Marshall et al., 2008). Depending on the experimental
model, TCDD-derived Tregs tended to secrete significant amounts of IL-10 or TGFβ in
response to both polyclonal and allogeneic stimuli (Marshall et al., 2008; Quintana et al.,
2008). Interestingly, in one study, exposure of murine immune cells to 6-formylindolo(3,2-
b) carbazole (another AhR ligand) in combination with TGFβ resulted in the formation of
pro-inflammatory IL-17-secreting T-cells, that could exacerbate inflammation in vivo
(Quintana et al., 2008).
It remains to be determined whether the generation of IL-10- or TGFβ-producing CD4+ T-
cells is a major component of TCDD-induced immunosuppression in experimental animals.
Proposed mechanisms by which AhR signaling might promote Treg differentiation include
reduction in CD62L expression in T-cells (Funatake et al., 2004, 2005), regulation of FoxP3
expression (Quintana et al., 2008; Hauben et al., 2008; Kimura et al., 2008), and/or
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modulation of DC antigen presentation. Antigen presentation by DC plays a key role in
converting naïve T-cells into adaptive Tregs. TCDD-induced activation of the AhR causes an
increase in CTLA-4 expression in T-cells that may induce tolerogenic DC (Funatake et al.,
2005). In the absence of the appropriate cytokines, DC can induce clonal deletion, anergy or
tolerogenic regulatory T-cells (Vorderstrasse and Kerkvliet, 2001; Thorstenson and Khoruts,
2001; Yamazaki et al., 2006). In addition, signaling through the AhR may up-regulate TGFβ
signaling, promoting the expansion and function of Tregs (Huber et al., 2004).
The AhR has also been reported to play a role in the development of TH17 cells (Quintana et
al., 2008; Veldhoen et al., 2008a). TH17 cells are characterized by their secretion of pro-
inflammatory cytokines IL-17 and IL-22. The ligand-activated AhR regulates expression of
these cytokines in tissue culture. A role for the AhR in the regulation of TH17 cells is
supported further by the observation that the absolute number of TH17 cells is reduced in
AhR null mice upon induction of Experimental Autoimmune Encephalomyelitis (Veldhoen
et al., 2008b). Because TH17 cells promote the immune response and Tregs are known to
decrease immune reactivity, a model has emerged suggesting that the Treg/TH17 balance
distinguishes an effective immune response and self-antigen tolerance from chronic
infection or autoimmunity. Preliminary evidence from multiple laboratories has suggested
that the AhR modifies the Treg/TH17 cell balance through modifying the cytokine milieu.
The mechanism at work may be related to the fact that TGFβ induces Treg differentiation,
while the presence of IL-6 leads to TGFβ-dependent TH17 cell production. Elucidating the
specific transcriptional targets of the AhR that result in the induction of Tregs through the
used of potent and specific AhR ligands such as TCDD that may provide the most direct
route to understand signaling steps by which the AhR influences the immune system.
Concluding remarks
The concept of regulatory or suppressor cells having a role in chemical-induced immune
system toxicology has been somewhat understudied. However, it is now recognized that
Tregs play a critical role in maintaining the careful balancing act that allows the immune
system to respond appropriately in the face of infection or disease, resolve when the
challenge has diminished, and fail to respond to self-antigens. As shown by the speakers in
this symposium, various immunoregulatory T-cell subsets may be induced by environmental
chemicals and protein allergens. Chemical-induced alterations in Tregs number or function
may be of pivotal importance in the clinical outcomes following chemical exposure and
further research is needed to elucidate the role of Tregs in chemical-induced modulation of
immune function and how this may impact human health and the burden of disease.
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